肝癌肝移植术后复发转移的防治策略和靶向免疫治疗

Prevention and therapeutic strategies and targeted immunotherapy for hepatocellular carcinoma recurrence and metastasis after liver transplantation

  • 摘要: 随着肝移植技术的发展和成熟,肝移植已成为治疗肝细胞癌(肝癌)的重要治疗手段之一,术后肿瘤复发转移是影响受者长期生存的重要原因之一,研究肝癌肝移植术后肿瘤复发转移的防治策略是提高肝癌肝移植受者临床疗效的关键。对肝癌肝移植受者肿瘤复发转移进行密切监测、积极预防、早期诊断,综合手术治疗、局部治疗特别是靶向免疫治疗等在内的多种治疗方式,制定术后个体化防治策略,对于肝癌肝移植术后肿瘤复发转移的防治具有重要意义。本文对肝癌肝移植术后肿瘤复发转移的监测、诊断、预防和治疗进行综述,以期为肝移植受者术后肿瘤复发转移的防治提供参考,提高临床肝移植疗效,改善受者生存质量。

     

    Abstract: With the development and maturity of liver transplant techniques, liver transplantation has become one of the vital treatment options for hepatocellular carcinoma (HCC). Postoperative recurrence and metastasis of HCC after liver transplantation is one of critical factors that affect the long-term survival of recipients. Exploring the prevention and therapeutic strategies for HCC recurrence and metastasis after liver transplantation plays a pivotal role in improving the clinical efficacy of liver transplantation for HCC recipients. Intimate monitoring, active prevention, early diagnosis, comprehensive surgical treatment and local treatment, especially targeted immunotherapy, and individualized prevention and therapeutic strategies are of significance for the prevention and treatment of HCC recurrence and metastasis after liver transplantation. In this article, the monitoring, diagnosis, prevention and treatment of tumor recurrence and metastasis after liver transplantation for HCC were reviewed, aiming to provide reference for the prevention and treatment of tumor recurrence and metastasis after liver transplantation, enhancing clinical efficacy of liver transplantation and prolonging the survival of recipients.

     

/

返回文章
返回